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Abstract
Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women of reproductive age. The psychiatric disorders accompa-
nying the clinical symptoms and hormonal abnormalities are important, but underestimated, aspects in PCOS. Obesity, hirsutism, acne, 
menstrual disturbances and infertility play important roles in lowering the quality of life in women with PCOS. Depression and anxiety are 
more often observed in patients with PCOS than in healthy women. Some authors consider that there is a relationship between valproic 
acid treatment of bipolar disease and PCOS. There have been reports that in women with PCOS anorexia nervosa, bulimia nervosa and 
other unspecified eating disorders are found more often than in the general population. (Endokrynol Pol 2012; 63 (6): 488–491)
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Streszczenie
Zespół wielotobielowatych (policystycznych) jajników (PCOS, polycystic ovary syndrome) jest częstym schorzeniem endokrynologicznym 
występującym u kobiet w wieku rozrodczym. Ważnym, choć niedocenianym, aspektem są zaburzenia psychiczne towarzyszące objawom 
klinicznym i nieprawidłowościom hormonalnym istniejącym w tym zespole. Otyłość, hirsutyzm, trądzik, zaburzenia miesiączkowania oraz 
niepłodność istotnie wpływają na obniżenie jakości życia kobiet z PCOS. U pacjentek z tym zespołem, częściej niż w populacji zdrowych 
kobiet, rozpoznawana jest depresja i zaburzenia lękowe. Ponadto uważa się, że istnieje związek między stosowaniem kwasu walpro-
inowego w chorobie dwubiegunowej a rozwojem PCOS. Istnieją również doniesienia o częstszym występowaniu zaburzeń odżywiania 
u kobiet z PCOS, takich jak: bulimia, jadłowstręt psychiczny i niespecyficzne zaburzenia jedzenia. (Endokrynol Pol 2012; 63 (6): 488–491)
Słowa kluczowe: PCOS, jakość życia, depresja, choroba dwubiegunowa, zaburzenia odżywiania
Polycystic ovary syndrome (PCOS) is one of the com-
monest endocrine disorders in women of reproductive 
age. For the diagnosis of this syndrome the Rotterdam 
Criteria are used: polycystic ovary syndrome is diag-
nosed in the presence of at least two of three criteria: 
menstrual disorders or amenorrhoea with chronic 
lack of ovulation, clinical and/or biochemical features 
of hyperandrogenism, and the presence of polycystic 
ovaries in ultrasonography after the exclusion of other 
endocrine disorders [1].
The prevalence of PCOS varies depending on the 
criteria for diagnosis. According to most studies which 
engage the NIH criteria it concerns 5–10% of premeno-
pausal women [1]. There are reports that the incidence 
of PCOS diagnosed on the basis of other criteria is 
much more frequent. In a study aimed at assessing the 
incidence of PCOS in 728 women from South Australia, 
PCOS was shown in 8.7% of the women according to 
the NIH criteria, in 17.8% according to the Rotterdam 
criteria, and in 12% according to the AES criteria [2]. 
There are some metabolic complications included in the 
clinical picture of PCOS, such as obesity, insulin resist-
ance, type 2 diabetes, dyslipidaemia and increased risk 
of developing cardiovascular disease. The relationship 
of PCOS with psychiatric disorders is less well known 
and we believe has been underestimated, although 
a reduced quality of life, depression, anxiety disorders 
and eating disorders occur in women with PCOS with 
increased frequency compared to the general popula-
tion [3–10].
Reduced quality of life indicators
According to the WHO definition of 1948, health 
is a state of physical, mental and social well-being 
and not merely the absence of disease. There is also 
a term ‘quality of life’, introduced by Schipper, which 
is related to the above definition of health [11]. Quality 
of life depending on health (HRQOL, Health Related 
Quality of Life) enables the assessment of the thera-
peutic process from the perspective of the patient. 
A HRQOL survey is carried out by means of ques-
tionnaires, general and specific to a given disease. 
General questionnaires assess the overall relation-
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ships between patient health status and factors such 
as emotional state, family relations, and professional 
activity. Specific questionnaires are divided into two 
categories, focusing on specific areas of patient func-
tioning and around the phenomena arising from the 
disease itself [11, 12].
The symptoms of polycystic ovary syndrome, such 
as hirsutism, acne, menstrual disturbances, infertility 
and obesity are strong factors that can influence the 
quality of life. A series of studies, using both question-
naires general and specific for PCOS, has been carried 
out mainly in Great Britain, the United States and 
Germany. The most commonly used questionnaires 
were the Short Form-36 (SF-36), and the only available 
one specific to polycystic ovary syndrome, PCOSQ 
[12]. All of these studies, mostly case-controlled, have 
shown that PCOS significantly reduces quality of life 
compared to healthy women [3, 4, 6, 7, 13] or patients 
with other mild gynaecological problems [10, 14]. An-
other case-control, the study by Coffey et al., has shown 
that women with PCOS have a 20% lower quality of life 
than patients with asthma, diabetes mellitus, epilepsy 
and chronic back pain [5].
According to most studies, obesity is the most no-
ticeable factor that lowers the quality of life in PCOS 
patients. On a scale where 1 means the worst quality of 
life, and 7 the best, obesity reaches an average value of 
2.1 [5], 2.33 [15], 2.85 [7], 2.86 [4] and 2.94 [10]. 
Infertility is the second most important factor in-
fluencing negatively the quality of life in women with 
PCOS. Trent et al. studied 97 adolescents with this 
syndrome and compared them to 186 healthy women 
matched for age [16]. Patients with PCOS significantly 
more often (3.4 times) had concerns about their ability 
to become pregnant in the future, which corresponded 
to the reduced quality of life indicators.
Hirsutism is another symptom of PCOS that plays 
a significant role in reducing quality of life in women 
with this syndrome. Lipton et al. studied 88 women with 
hirsutism localised on the face and found a reduction 
in quality of life in the field of social life and interper-
sonal relationships [17]. The studied patients spent an 
average of 104 minutes a week checking the degree of 
hair excess: two thirds by looking in the mirror and 
76% by touch. 
Cultural factors have an important influence on the 
relationship between the individual components or 
symptoms of PCOS and deterioration in quality of life. 
Hashimoto’s study showed that in Brazilian women 
(102 women with PCOS) compared to Austrian ones 
(31 women with PCOS), infertility had a greater impact 
on HRQL than obesity [18]. In turn, Schmid has shown 
that Muslim women suffered more from infertility than 
obesity [19].
Depression
Depressive disorders are defined as a deep and per-
sistent lowering of mood. According to DSM-IV (Di-
agnostic and Statistical Manual of Mental Disorders) 
major depression, dystymia and unspecified depressive 
disorders can be distinguished. According to the data 
from the NIH (National Institutes of Health), depres-
sion affects about 5% of the population in a year, and 
13% of people during their whole life. Almost half of 
people with depression have suicidal thoughts, and 
one third attempt suicide. Depression occurs most 
frequently between the ages of 20 and 40. A review of 
the literature from 1965 to 2008, made by Accortt et al., 
has shown that women suffer from it almost twice as 
often as men [20]. These findings suggest the need for 
greater recognition of depression, especially in groups 
of increased risk, which include PCOS patients.
Many researchers in longitudinal studies have 
shown an increased incidence of depression in women 
with PCOS [10, 21, 22], and some have even reported 
a seven-fold increase in the incidence of suicide among 
women with this syndrome [13]. Kerchner et al. found 
depression in 40% of 60 women diagnosed with PCOS 
[21]. In this group, ten women met the criteria for the 
diagnosis of depression, while 14 others had already 
been receiving antidepressants. After comparing 
these findings with the results from previous studies 
in the same group of women, it appeared that within 
an average of 22 months 19% (11 of 60) of women 
with PCOS have developed depression. Hollinrake 
et al. assessed the prevalence of depression among 
103 women with PCOS compared to an equally-sized 
control group [22]. Depression, both previously diag-
nosed and treated, and newly found during the study, 
concerned 35% of patients with PCOS, compared to 
10.7% of women in the control group. Fatigue (96%) 
and sleep disturbances (88%) were the most com-
monly reported symptoms of depression. The risk of 
depressive disorders in a subgroup of obese women 
with PCOS was assessed as 44% compared to 14.7% 
in obese women from the control group. Women with 
PCOS and depression had higher BMI and lower val-
ues of insulin sensitivity indices compared to PCOS 
patients without depression.
Anxiety disorders often coexist with depression. On 
the basis of a questionnaire study, Benson et al. found 
anxiety disorders in 34% of 448 women with PCOS. 
These symptoms were associated mainly with acne and 
fertility problems [23].
The same disorders found in PCOS that are associ-
ated with decreased quality of life contribute to the 
manifestation of depression. Among them are obesity, 
infertility, hirsutism and acne. Furthermore, it is be-
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lieved that increased levels of testosterone, which is one 
of the key abnormalities in PCOS, is associated with an 
increased risk of developing depression [24].
Bipolar disorder
Bipolar disorders are characterised by the alternating 
occurrence of periods of mania and depression. They 
are divided into bipolar disorder I (full-blown mania and 
major depression), bipolar disorder II (hypomania and 
episodes of major depression) and unspecified bipolar 
disorder (bipolar symptoms that do not meet criteria 
I or II). The incidence of bipolar disorder is about 1%. 
Women are more prone to bipolar disorder II [25].
There is little evidence on the relationship of bipolar 
disorder and PCOS. Opinions of the authors concern-
ing the links between these conditions are divergent. 
Some of them claim that the development of PCOS is 
influenced by the valproic acid (VPA) itself, which is 
used to treat bipolar disorder. Others believe that there 
is a direct relationship between both these diseases, and 
they explain it by disturbances that are common to PCOS 
and bipolar disorder at the hypothalamic-pituitary-ovary 
level [26] and the similarity of metabolic abnormalities in 
these diseases [26, 27]. Only a few studies have focused 
on the impact of the drugs used to treat bipolar disease, 
especially valproic acid, on the occurrence of menstrual 
disturbances [27–29]. McIntyre et al. compared 18 women 
treated with VPA with 20 female patients treated with 
lithium, and they found a higher incidence of menstrual 
disturbances in the first group (50% versus 15%) [29]. 
In addition, patients treated with VPA had significantly 
higher levels of androgens (total testosterone, free tes-
tosterone and androstenedione), more atherogenic lipid 
profile (higher total cholesterol, LDL cholesterol and tri-
glycerides, and lower HDL cholesterol levels) and higher 
serum leptin concentrations. In another study concerning 
80 women with bipolar disorder, PCOS was diagnosed 
in 6% of patients treated with VPA and in none treated 
with other antipsychotic drugs [28].
Klipstein et al. studied the incidence of bipolar dis-
order in 78 patients previously diagnosed with PCOS: 
28% of the women had been diagnosed with bipolar 
disorder or met the criteria for the diagnosis according to 
the MDS questionnaire (Mood Disorders Questionnaire) 
[26]. Ninety seven per cent of patients in whom bipolar 
disorder was diagnosed before or during the study had 
not been treated with valproic acid before the time of 
diagnosis of PCOS. So, valproic acid therapy alone can-
not explain the linkage between bipolar disorder and 
PCOS. Due to the coexistence of metabolic disturbances 
such as insulin resistance, obesity or hyperglycaemia, 
found in both these diseases, a common pathogenic 
background seems possible [26].
Eating disorders
According to DSM-IV, three types of eating disorders 
are distinguished: anorexia nervosa, bulimia nervosa, 
and periodic overeating (BED, binge-eating disorder). 
In addition, subgroups of non-specific eating disorders 
(EDNOS, Eating Disorders Not Otherwise Specified) 
are recognised. Ninety per cent of eating disorders oc-
cur in women, mainly in teenagers and young women. 
Bulimia occurs in 1.1 to 4.2% of young women, anorexia 
nervosa in 0.5 to 3.7% and BED concerns 26% of women. 
EDNOS is the commonest eating disorder: it concerns 
approximately 60% of people presenting to psychiatric 
clinics because of problems with eating [30]. As dissat-
isfaction with self-appearance is often associated with 
PCOS and plays an important role in the pathogenesis 
of eating disorders, a relationship between these two 
diseases seems likely.
McCluskey et al. found that one third of 153 studied 
women with PCOS fulfilled the diagnostic criteria for 
eating disorders, and bulimia was diagnosed in 6% 
of them [31]. Other studies have shown an increased 
incidence of polycystic ovaries on ultrasound image in 
women with bulimia, and even the normalisation of 
these changes after recovery from bulimia [9]. Morgan 
et al. studied the prevalence of eating disorders in 
a group of 80 women with hirsutism, including 68 pa-
tients with PCOS [32]. In 36.3% of the women, eating 
disorders were diagnosed (all the women were from 
the PCOS group): in 22.5% EDNOS was recognised, in 
12.6% bulimia nervosa and in 1.3% anorexia nervosa.
In contrast to the abovementioned results, Michel-
more et al. found no association between PCOS or 
polycystic ovaries on the ultrasound image and eat-
ing disorders [33]. They studied a group of 230 young 
women. Picture of polycystic ovaries in ultrasound 
was found in 74 women (33%), and 59 of them were 
diagnosed with PCOS. Thirty per cent of the partici-
pants admitted to episodes of binge eating, while 4% 
had used extreme methods to maintain body weight. 
In two women bulimia was diagnosed: one of them 
had normal ovaries on ultrasound scanning, in the 
other an ultrasound examination was not performed. 
In five women (three with PCOS and two with normal 
ovaries), BED was diagnosed. No statistically significant 
differences between the incidence of eating disorders 
in women with PCOS and women with normal ovaries 
were found.
Summary
PCOS is the commonest endocrine disorder in pre-
menopausal women. More and more is known about 
the relationship between PCOS and impaired mental 
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health. However, it seems that clinicians still attach too 
little importance to this aspect of the disease. It should 
be remembered that significantly reduced quality of life 
and the more frequent occurrence of depression and 
eating disorders may be associated with this condition.
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